Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ibuprofen with Bupivacaine for Pain After Laparoscopic Gynecology
NCT06046105Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and ibuprofen in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Post-operative pain severity by VAS at 24 hours. Status: unknown.
02
Drugs
dexmedetomidineibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06046105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046105.